You have no items in your shopping cart.
Availability: In Stock
Brand Name : Ultravist 0.623gm Infusion
Composition : Iopromide (0.623gm)
Manufactured By : Zydus Cadila
Form : bottle
Packing : 100 ml in 1 bottle
Ultravist 0.623gm Infusion Description:
Iopromide belongs to a class of drugs known as Iodinated radiographic contrast agent. It enhances imaging due to its high Iodine content attenuating the beam of X-rays during examination.
Ultravist 0.623gm Infusion is used in diagnosis of disease of spinal cord.
Headache, Altered taste, Vomiting, Chest pain, Injection site pain, Back pain, Nausea, Infusion site reaction, Abnormal vision, Decreased blood pressure, Frequent urge to urinate.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Is Iopromide radioactive?
No. Iopromide is not radioactive
Is Iopromide water soluble?
Yes. Iopromide is a water soluble X-ray contrast agent for intravascular administration.
Buy Ultravist 0.623gm Infusion Online From India At Best Price
If you are looking to buy Iopromide (0.623gm) (100 ml in 1 bottle) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Ultravist 0.623gm Infusion in -
South East Asia - China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) - Iran, Saudi Arabia, Jordan.
North America - Venezuela, USA (United States of America), Suriname.
South America - Argentina, Chile, Colombia, Peru, Venezuela.
Europe - Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS - Moldova, Uzbekistan, Kyrgyzstan.
African Countries - Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries - Malaysia, Egypt, Australia, Italy and New Zealand.